MA42268A - Compositions antimicrobiennes contenant des cannabinoïdes - Google Patents

Compositions antimicrobiennes contenant des cannabinoïdes

Info

Publication number
MA42268A
MA42268A MA042268A MA42268A MA42268A MA 42268 A MA42268 A MA 42268A MA 042268 A MA042268 A MA 042268A MA 42268 A MA42268 A MA 42268A MA 42268 A MA42268 A MA 42268A
Authority
MA
Morocco
Prior art keywords
compositions containing
antimicrobial compositions
containing cannabinoids
cannabinoids
antimicrobial
Prior art date
Application number
MA042268A
Other languages
English (en)
Inventor
George Anastassov
Lekhram Changoer
Damme Phillipus Van
Original Assignee
Axim Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axim Biotechnologies Inc filed Critical Axim Biotechnologies Inc
Publication of MA42268A publication Critical patent/MA42268A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/16Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088Liquid substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18Liquid substances or solutions comprising solids or dissolved gases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
MA042268A 2015-06-23 2016-06-21 Compositions antimicrobiennes contenant des cannabinoïdes MA42268A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562183573P 2015-06-23 2015-06-23

Publications (1)

Publication Number Publication Date
MA42268A true MA42268A (fr) 2018-05-02

Family

ID=57585447

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042268A MA42268A (fr) 2015-06-23 2016-06-21 Compositions antimicrobiennes contenant des cannabinoïdes

Country Status (5)

Country Link
US (3) US20160374958A1 (fr)
EP (1) EP3313394A4 (fr)
HK (1) HK1254812A1 (fr)
MA (1) MA42268A (fr)
WO (1) WO2016209802A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3352855A4 (fr) 2015-09-22 2019-05-22 Vitality Biopharma, Inc. Promédicaments à base de glycosides cannabinoïdes et méthodes de synthèse
US10053407B2 (en) * 2016-06-01 2018-08-21 S&B Pharma, Inc. Crystalline cannabidivarin
CA3081755A1 (fr) * 2016-11-07 2018-05-11 Avidas Pharmaceuticals Llc Formulations de cannabinoides therapeutiques et procedes pour leur utilisation
WO2018148785A1 (fr) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations de cannabinoïdes pour le traitement de la dermatite et de maladies cutanées inflammatoires
CA3053505A1 (fr) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations de cannabinoides pour le traitement du psoriasis
WO2018148786A1 (fr) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations de cannabinoïdes pour le traitement de l'acné
WO2018148787A1 (fr) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations de cannabinoïdes pour le traitement du psoriasis
US20220323401A1 (en) * 2017-02-15 2022-10-13 Botanix Pharmaceuticals Ltd. Formulations of cannabinoids for the treatment of acne
US20210401768A1 (en) * 2017-02-15 2021-12-30 Botanix Pharmaceuticals Ltd. Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
WO2018165078A1 (fr) * 2017-03-06 2018-09-13 Korbutov Jack D Compositions dermatologiques contenant des cannabinoïdes et leurs procédés d'utilisation
EP3606343A1 (fr) 2017-04-04 2020-02-12 Gojo Industries Inc Procédés et composés permettant d'augmenter l'efficacité virucide dans des systèmes hydroalcooliques
CA3063186A1 (fr) * 2017-05-09 2018-11-15 Vitality Biopharma, Inc. Compositions antimicrobiennes comprenant des cannabinoides et leurs methodes d'utilisation
US10272051B2 (en) 2017-08-28 2019-04-30 Axim Biotechnologies, Inc. Method to treat atopic dermatitis
US20190060250A1 (en) * 2017-08-28 2019-02-28 Axim Biotechnologies, Inc. Method to treat psoriasis
CN109498605B (zh) * 2017-09-15 2020-12-01 汉义生物科技(北京)有限公司 一种治疗妇科炎症的组合物及其在外用组合物中的应用
AU2019210704A1 (en) * 2018-01-24 2020-08-06 Botanix Pharmaceuticals Ltd Cannabinoid dosing regime for psoriasis
CN111936126A (zh) * 2018-01-24 2020-11-13 博塔尼克斯制药有限公司 用于皮炎和炎症性皮肤病的大麻素给药方案
CA3089346A1 (fr) * 2018-01-24 2019-08-01 Botanix Pharmaceuticals Ltd Regime de dosage de cannabinoide pour l'acne
CA3089750A1 (fr) * 2018-01-29 2019-08-01 Solantech Inc. Methodes de traitement et/ou de prevention d'escarres de decubitus a l'aide de nabilone
CA3098010A1 (fr) * 2018-04-27 2019-10-31 Thomas Jefferson University Materiaux a base de chanvre nanofiles
WO2019244160A1 (fr) * 2018-06-20 2019-12-26 Tel Ari Ruben Compositions hyperosmotiques antimicrobiennes non irritantes contenant du cannabidiol
WO2020000024A1 (fr) * 2018-06-28 2020-01-02 Botanix Pharmaceuticals Ltd Traitement antibactérien utilisant des combinaisons de cannabinoïdes
WO2020024056A1 (fr) * 2018-08-01 2020-02-06 Lazar Eve Compositions comprenant des cannabinoïdes et matériau absorbable et utilisations associées
WO2020051284A1 (fr) * 2018-09-05 2020-03-12 Nemus Bioscience, Inc. Cannabinoïdes pour le traitement d'infections à gram positif comprenant des souches bactériennes antibiorésistantes
EP3935036A1 (fr) * 2019-03-05 2022-01-12 Colleen Smith Compositions vétérinaires et procédés d'utilisation associés
AU2020297660A1 (en) * 2019-06-18 2021-12-09 Botanix Pharmaceuticals Limited Antibacterial dosage regime using cannabinoids
WO2020257588A1 (fr) * 2019-06-20 2020-12-24 Shaman Naturals, Llc Compositions pour la prévention et le traitement d'infections virales
CN110283050A (zh) * 2019-07-01 2019-09-27 大兴安岭林格贝寒带生物科技股份有限公司 利用超高压技术富集纯化大麻二酚的方法
US20210177740A1 (en) * 2019-12-11 2021-06-17 Joel Studin Transpore delivery of cannabinoid and uses thereof
WO2021155390A1 (fr) * 2020-01-14 2021-08-05 Shaman Naturals, Llc. Compositions antimicrobiennes
WO2021152575A1 (fr) * 2020-01-30 2021-08-05 Innocan Pharma Ltd. Compositions pour le traitement des hémorroïdes
US20230137655A1 (en) * 2020-03-20 2023-05-04 Credo Science, Llc Antimicrobial compositions and methods
CN111557900B (zh) * 2020-05-22 2023-05-12 广州大洲生物医药科技有限公司 大麻二酚乳膏剂,其制备方法及用途
GB202010268D0 (en) * 2020-07-03 2020-08-19 Novabiotics Ltd Nail formulations and treatment regimes
US20220040623A1 (en) * 2020-08-07 2022-02-10 Bohde John Mold and fungal (mycotoxin) toxin remediation
WO2022077271A1 (fr) * 2020-10-14 2022-04-21 Huang Yu Fen Flavonoïdes polymères et leur utilisation
US20220125755A1 (en) * 2020-10-24 2022-04-28 Kevin Hazen Cannabis time release apparatus and method of manufacture thereof
US20230085692A1 (en) * 2021-08-18 2023-03-23 P2 Science, Inc. Cannabis species as industrial chemical feedstocks
US20230310297A1 (en) 2022-04-01 2023-10-05 TF Holdings LLC Skin treatment composition containing cannabinoids
US20240041901A1 (en) 2022-08-02 2024-02-08 TF Holdings LLC Wound treatment topical composition containing cannabinoids

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223244A (en) * 1988-06-20 1993-06-29 Shiseido Company, Ltd. Aerosol composition
US5780020A (en) * 1996-10-28 1998-07-14 The Proctor & Gamble Company Methods and compositions for reducing body odor
US7025992B2 (en) * 2001-02-14 2006-04-11 Gw Pharma Limited Pharmaceutical formulations
US20040229939A1 (en) * 2003-02-14 2004-11-18 Chowdhury Dipak K. Tetrahydrocannabinol compositions and methods of manufacture and use thereof
CA2522231A1 (fr) * 2003-04-14 2004-10-21 Vectura Ltd Compositions pharmaceutiques comprenant de l'apomorphine pour l'inhalation pulmonaire
AU2013213706B2 (en) * 2005-11-07 2016-04-14 Murty Pharmaceuticals, Inc An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
JPWO2008111296A1 (ja) * 2007-03-09 2010-06-24 国立大学法人京都大学 角化の亢進に起因する皮膚疾患の予防及び治療のための医薬
GB2450493A (en) * 2007-06-25 2008-12-31 Gw Pharma Ltd Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors
US8222292B2 (en) * 2007-08-06 2012-07-17 Insys Therapeutics, Inc. Liquid cannabinoid formulations
AU2009345154A1 (en) * 2009-04-29 2011-12-22 University Of Kentucky Research Foundation Cannabinoid-containing compositions and methods for their use
PT2473475T (pt) * 2009-08-31 2017-08-02 Zynerba Pharmaceuticals Inc Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas
WO2013009928A1 (fr) * 2011-07-11 2013-01-17 Organic Medical Research Formulations de cannabinoïdes

Also Published As

Publication number Publication date
EP3313394A4 (fr) 2019-02-27
US11058646B2 (en) 2021-07-13
US10441552B2 (en) 2019-10-15
WO2016209802A1 (fr) 2016-12-29
EP3313394A1 (fr) 2018-05-02
HK1254812A1 (zh) 2019-07-26
US20160374958A1 (en) 2016-12-29
US20190209487A1 (en) 2019-07-11
US20200016095A1 (en) 2020-01-16

Similar Documents

Publication Publication Date Title
MA42268A (fr) Compositions antimicrobiennes contenant des cannabinoïdes
DK3240414T3 (da) Fungicide sammensætninger
GB2573068B (en) Antimicrobial Compositions
MA41212A (fr) Composition de soin oral contenant des cannabinoïdes
DK3361870T3 (da) Fungicidsammensætninger
DK3892302T3 (da) Sammensætninger indeholdende ibrutinib
GB2535666B (en) Antimicrobial compositions
DK3334282T3 (da) Uorganiske partikler indeholdende antimikrobielt metal
MA41976A (fr) Composition lubrifiante ultra-fluide
BR112016030366A2 (pt) composição antimicrobiana sinergística de piritiona de zinco
DK3416996T3 (da) Hærdelig sammensætning
BR112017001922A2 (pt) composições fungicidas
FR3041503B1 (fr) Projectiles oxodegradables contenant des pheromones
DK3334726T3 (da) Plinabulinsammensætninger
DK3253485T3 (da) No-holdige sammensætninger
DK3250182T3 (da) Dispergible sammensætninger
DK3451829T3 (da) Antimikrobielle sammensætninger
FR3020948B1 (fr) Composition antimicrobienne
PL3253232T3 (pl) Kompozycje przeciwdrobnoustrojowe
MA50787A (fr) Compositions fongicides
DK3397352T3 (da) Antiperspirantsammensætninger
DK3316857T3 (da) Multifasiske sammensætninger
MA44601A (fr) Composition ophtalmique contenant de la pvp-i
DK3393967T3 (da) Antimikrobiel polymersammensætning
DK3528791T3 (da) Dispergible sammensætninger